MG53-mediated cell membrane repair protects against acute kidney injury

Science Translational Medicine

Volumn 7, Issue 279, 2015, Pages

  Duann, Pu ^a   Li, Haichang ^a   Lin, Peihui ^a   Tan, Tao ^a   Wang, Zhen ^b   Chen, Ken ^b   Zhou, Xinyu ^a   Gumpper, Kristyn ^a   Zhu, Hua ^a   Ludwig, Thomas ^c   Mohler, Peter J ^a   Rovin, Brad ^a   Abraham, William T ^a   Zeng, Chunyu ^b   Ma, Jianjie ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; CISPLATIN; PROTEIN MG53; RECOMBINANT HUMAN MG53 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; MG53 PROTEIN, MOUSE; MITSUGUMIN 53, HUMAN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL MEMBRANE; CELL REGENERATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; HUMAN; HUMAN CELL; KIDNEY TUBULE EPITHELIUM; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROXIMAL TUBULAR EPITHELIUM; RENAL PROTECTION; REPERFUSION INJURY; ANIMAL; DOG; DRUG EFFECTS; FIBROSIS; KIDNEY; KIDNEY TUBULE; KNOCKOUT MOUSE; MALE; METABOLISM; NUDE MOUSE; PHENOTYPE; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ACUTE KIDNEY INJURY; ANIMALS; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL MEMBRANE; CISPLATIN; DOGS; FIBROSIS; HUMANS; KIDNEY; KIDNEY TUBULES; MALE; MICE; MICE, KNOCKOUT; MICE, NUDE; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 84925240556     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3010755     Document Type: Article

References (54)

1. A. Saito, H. Sato, N. Iino, T. Takeda, Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium. J. Biomed. Biotechnol. 2010, 403272 (2010).
2. E. I. Christensen, H. Birn, T. Storm, K. Weyer, R. Nielsen, Endocytic receptors in the renal proximal tubule. Physiology 27, 223-236 (2012).
3. T. C. Fuchs, P. Hewitt, Biomarkers for drug-induced renal damage and nephrotoxicity - An overview for applied toxicology. AAPS J. 13, 615-631 (2011).
4. R. P. Miller, R. K. Tadagavadi, G. Ramesh, W. B. Reeves, Mechanisms of cisplatin nephrotoxicity. Toxins 2, 2490-2518 (2010).
5. A. Linkermann, G. Chen, G. Dong, U. Kunzendorf, S. Krautwald, Z. Dong, Regulated cell death in AKI. J. Am. Soc. Nephrol. 25, 2689-2701 (2014).
6. H. K. Eltzschig, T. Eckle, Ischemia and reperfusion - From mechanism to translation. Nat. Med. 17, 1391-1401 (2011).
7. J. V. Bonventre, L. Yang, Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, 4210-4221 (2011).
8. H. J. Anders, D. A. Muruve, The inflammasomes in kidney disease. J. Am. Soc. Nephrol. 22, 1007-1018 (2011).
9. K. C. Leung, M. Tonelli, M. T. James, Chronic kidney disease following acute kidney injury - Risk and outcomes. Nat. Rev. Nephrol. 9, 77-85 (2013).
10. M. Z. Zhang, B. Yao, S. Yang, L. Jiang, S. Wang, X. Fan, H. Yin, K. Wong, T. Miyazawa, J. Chen, I. Chang, A. Singh, R. C. Harris, CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 122, 4519-4532 (2012).
11. P. L. McNeil, T. Kirchhausen, An emergency response team for membrane repair. Nat. Rev. Mol. Cell Biol. 6, 499-505 (2005).
12. P. L. McNeil, R. A. Steinhardt, Plasma membrane disruption: Repair, prevention, adaptation. Annu. Rev. Cell Dev. Biol. 19, 697-731 (2003).
13. R. Han, D. Bansal, K. Miyake, V. P. Muniz, R. M. Weiss, P. L. McNeil, K. P. Campbell, Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J. Clin. Invest. 117, 1805-1813 (2007).
14. D. Bansal, K. Miyake, S. S. Vogel, S. Groh, C. C. Chen, R. Williamson, P. L. McNeil, K. P. Campbell, Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423, 168-172 (2003).
15. C. Cai, H. Masumiya, N. Weisleder, N. Matsuda, M. Nishi, M. Hwang, J. K. Ko, P. Lin, A. Thornton, X. Zhao, Z. Pan, S. Komazaki, M. Brotto, H. Takeshima, J. Ma, MG53 nucleates assembly of cell membrane repair machinery. Nat. Cell Biol. 11, 56-64 (2009).
16. C. M. Cao, Y. Zhang, N. Weisleder, C. Ferrante, X. Wang, F. Lv, R. Song, M. Hwang, L. Jin, J. Guo, W. Peng, G. Li, M. Nishi, H. Takeshima, J. Ma, R. P. Xiao, MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation 121, 2565-2574 (2010).
17. N. Weisleder, N. Takizawa, P. Lin, X. Wang, C. Cao, Y. Zhang, T. Tan, C. Ferrante, H. Zhu, P. J. Chen, R. Yan, M. Sterling, X. Zhao, M. Hwang, M. Takeshima, C. Cai, H. Cheng, H. Takeshima, R. P. Xiao, J. Ma, Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci. Transl. Med. 4, 139ra85 (2012).
18. C. Cai, N. Weisleder, J. K. Ko, S. Komazaki, Y. Sunada, M. Nishi, H. Takeshima, J. Ma, Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J. Biol. Chem. 284, 15894-15902 (2009).
19. P. McNeil, Membrane repair redux: Redox of MG53. Nat. Cell Biol. 11, 7-9 (2009).
20. J. S. Yi, J. S. Park, Y.M. Ham, N. Nguyen, N. R. Lee, J. Hong, B. W. Kim, H. Lee, C. S. Lee, B. C. Jeong, H. K. Song, H. Cho, Y. K. Kim, J. S. Lee, K. S. Park, H. Shin, I. Choi, S. H. Lee, W. J. Park, S. Y. Park, C. S. Choi, P. Lin, M. Karunasiri, T. Tan, P. Duann, H. Zhu, J. Ma, Y. G. Ko, MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat. Commun. 4, 2354 (2013).
21. Y. Jia, K. Chen, P. Lin, G. Lieber, M. Nishi, R. Yan, Z. Wang, Y. Yao, Y. Li, B. A. Whitson, P. Duann, H. Li, X. Zhou, H. Zhu, H. Takeshima, J. C. Hunter, R. L. McLeod, N. Weisleder, C. Zeng, J. Ma, Treatment of acute lung injury by targeting MG53-mediated cell membrane repair. Nat. Commun. 5, 4387 (2014).
22. E. D. Klootwijk, M. Reichold, R. J. Unwin, R. Kleta, R. Warth, D. Bockenhauer, Renal Fanconi syndrome: Taking a proximal look at the nephron. Nephrol. Dial. Transplant., 10.1093/ndt/gfu377 (2014).
23. L. C. Racusen, C. Monteil, A. Sgrignoli, M. Lucskay, S. Marouillat, J. G. Rhim, J. P. Morin, Cell lines with extended in vitro growth potential from human renal proximal tubule: Characterization, response to inducers, and comparison with established cell lines. J. Lab. Clin. Med. 129, 318-329 (1997).
24. T. Ichimura, E. J. Asseldonk, B. D. Humphreys, L. Gunaratnam, J. S. Duffield, J. V. Bonventre, Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118, 1657-1668 (2008).
25. Q. Lin, Y. Chen, J. Lv, H. Zhang, J. Tang, L. Gunaratnam, X. Li, L. Yang, Kidney injury molecule-1 expression in IgA nephropathy and its correlation with hypoxia and tubulointerstitial inflammation. Am. J. Physiol. Renal Physiol. 306, F885-F895 (2014).
26. R. Safirstein, J. Winston, M. Goldstein, D. Moel, S. Dikman, J. Guttenplan, Cisplatin nephrotoxicity. Am. J. Kidney Dis. 8, 356-367 (1986).
27. K. U. Wensing, G. Ciarimboli, Saving ears and kidneys from cisplatin. Anticancer Res. 33, 4183-4188 (2013).
28. U. M. Ohndorf, M. A. Rould, Q. He, C. O. Pabo, S. J. Lippard, Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature 399, 708-712 (1999).
29. G. Speelmans, R. W. Staffhorst, K. Versluis, J. Reedijk, B. de Kruijff, Cisplatin complexes with phosphatidylserine in membranes. Biochemistry 36, 10545-10550 (1997).
30. M. Jensen, M. Bjerring, N. C. Nielsen, W. Nerdal, Cisplatin interaction with phosphatidylserine bilayer studied by solid-state NMR spectroscopy. J. Biol. Inorg. Chem. 15, 213-223 (2010).
31. J. H. Kramer, V. Misík, W. B. Weglicki, Lipid peroxidation-derived free radical production and postischemic myocardial reperfusion injury. Ann. N. Y. Acad. Sci. 723, 180-196 (1994).
32. A. P. Singh, A. Junemann, A. Muthuraman, A. S. Jaggi, N. Singh, K. Grover, R. Dhawan, Animal models of acute renal failure. Pharmacol. Rep. 64, 31-44 (2012).
33. R. Shakya, T. Gonda, M. Quante, M. Salas, S. Kim, J. Brooks, S. Hirsch, J. Davies, A. Cullo, K. Olive, T. C. Wang, M. Szabolcs, B. Tycko, T. Ludwig, Hypomethylating therapy in an aggressive stromarich model of pancreatic carcinoma. Cancer Res. 73, 885-896 (2013).
34. R. Shakya, L. J. Reid, C. R. Reczek, F. Cole, D. Egli, C. S. Lin, D. G. deRooij, S. Hirsch, K. Ravi, J. B. Hicks, M. Szabolcs, M. Jasin, R. Baer, T. Ludwig, BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science 334, 525-528 (2011).
35. M. Sekine, T. Monkawa, R. Morizane, K. Matsuoka, C. Taya, Y. Akita, K. Joh, H. Itoh, M. Hayashi, Y. Kikkawa, K. Kohno, A. Suzuki, H. Yonekawa, Selective depletion of mouse kidney proximal straight tubule cells causes acute kidney injury. Transgenic Res. 21, 51-62 (2012).
36. H. G. Rennke, Y. Patel, M. A. Venkatachalam, Glomerular filtration of proteins: Clearance of anionic, neutral, and cationic horseradish peroxidase in the rat. Kidney Int. 13, 278-288 (1978).
37. H. G. Rennke, M. A. Venkatachalam, Glomerular permeability of macromolecules. Effect of molecular configuration on the fractional clearance of uncharged dextran and neutral horseradish peroxidase in the rat. J. Clin. Invest. 63, 713-717 (1979).
38. A. Shaw, Update on acute kidney injury after cardiac surgery. J. Thorac. Cardiovasc. Surg. 143, 676-681 (2012).
39. C. Cai, H. Masumiya, N. Weisleder, Z. Pan, M. Nishi, S. Komazaki, H. Takeshima, J. Ma, MG53 regulates membrane budding and exocytosis in muscle cells. J. Biol. Chem. 284, 3314-3322 (2009).
40. R. Song, W. Peng, Y. Zhang, F. Lv, H. K. Wu, J. Guo, Y. Cao, Y. Pi, X. Zhang, L. Jin, M. Zhang, P. Jiang, F. Liu, S. Meng, C. M. Cao, R. P. Xiao, Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature 494, 375-379 (2013).
41. N. Nguyen, J. S. Yi, H. Park, J. S. Lee, Y. G. Ko, Mitsugumin 53 (MG53) ligase ubiquitinates focal adhesion kinase during skeletal myogenesis. J. Biol. Chem. 289, 3209-3216 (2014).
42. L. L. Ma, F. J. Zhang, L. B. Qian, F. J. Kong, J. F. Sun, C. Zhou, Y. N. Peng, H. J. Xu, W. N. Wang, C. Y. Wen, M. H. Zhu, G. Chen, L. N. Yu, X. B. Liu, J. A. Wang, M. Yan, Hypercholesterolemia blocked sevoflurane-induced cardioprotection against ischemia-reperfusion injury by alteration of the MG53/RISK/GSK3β signaling. Int. J. Cardiol. 168, 3671-3678 (2013).
43. H. Yuan, Y. Niu, X. Liu, F. Yang, W. Niu, L. Fu, Proteomic analysis of skeletal muscle in insulin-resistant mice: Response to 6-week aerobic exercise. PLOS One 8, e53887 (2013).
44. Y. Xu, L. L. Ma, C. Zhou, F. J. Zhang, F. J. Kong, W. N. Wang, L. B. Qian, C. C. Wang, X. B. Liu, M. Yan, J. A. Wang, Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. PLOS One 8, e76652 (2013).
45. H. Tamemoto, T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, T. Hayakawa, Y. Terauchi, K. Ueki, Y. Kaburagi, S. Satoh, H. Sekihara, S. Yoshioka, H. Horikoshi, Y. Furuta, Y. Ikawa, M. Kasuga, Y. Yazaki, S. Aizawa, Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182-186 (1994).
46. Y. Terauchi, K. Iwamoto, H. Tamemoto, K. Komeda, C. Ishii, Y. Kanazawa, N. Asanuma, T. Aizawa, Y. Akanuma, K. Yasuda, T. Kodama, K. Tobe, Y. Yazaki, T. Kadowaki, Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and β cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J. Clin. Invest. 99, 861-866 (1997).
47. L. B. Waddell, F. A. Lemckert, X. F. Zheng, J. Tran, F. J. Evesson, J. M. Hawkes, A. Lek, N. E. Street, P. Lin, N. F. Clarke, A. P. Landstrom, M. J. Ackerman, N. Weisleder, J.Ma, K. N. North, S. T. Cooper, Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch. J. Neuropathol. Exp. Neurol. 70, 302-313 (2011).
48. P. Lin, H. Zhu, C. Cai, X. Wang, C. Cao, R. Xiao, Z. Pan, N. Weisleder, H. Takeshima, J. Ma, Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair. FASEB J. 26, 1875-1883 (2012).
49. H. Zhu, P. Lin, G. De, K. H. Choi, H. Takeshima, N. Weisleder, J. Ma, Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair. J. Biol. Chem. 286, 12820-12824 (2011).
50. 3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ. Res. 99, 494-500 (2006).
51. A. Parenti, X. L. Cui, U. Hopfer, M. Ziche, J. G. Douglas, Activation of MAPKs in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats. Hypertension 35, 1160-1166 (2000).
52. H. M. Wilson, K. N. Stewart, Glomerular epithelial and mesangial cell culture and characterization. Methods Mol. Biol. 806, 187-201 (2012).
53. W. Lieberthal, R. Fuhro, C. C. Andry, H. Rennke, V. E. Abernathy, J. S. Koh, R. Valeri, J. S. Levine, Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am. J. Physiol. Renal Physiol. 281, F693-F706 (2001).
54. B. Schröppel, B. Krüger, L. Walsh, M. Yeung, S. Harris, K. Garrison, J. Himmelfarb, S. M. Lerner, J. S. Bromberg, P. L. Zhang, J. V. Bonventre, Z. Wang, A. B. Farris, R. B. Colvin, B. T. Murphy, J. P. Vella, Tubular expression of KIM-1 does not predict delayed function after transplantation. J. Am. Soc. Nephrol. 21, 536-542 (2010).